共 8 条
[1]
Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Moustapha A,Naso A. Nahlawi M. et al. Circulation . 1998
[2]
Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls. Yu HH,Joubran R. Asmi M. et al. Clinical Chemistry . 2000
[3]
The role of homocysteine in end -stage renal disease. Yeun JY. Seminars in Dialysis . 1998
[4]
Prevalence and determinants of hyperhomo -cysteinemia in hemodialysis and peritoneal dialysis. Moustapha A. Gupta A. Robinson K. et al. Kidney International . 1999
[5]
Plasma homocysteine levels and mortality in patients with coronary artery disease. Nygard 0. Norderhaug JE. Refsum H. et al. The New England Journal of Medicine . 1997
[6]
Cardiovascular disorders (risk assessment). Jacobsen DW. Clin Chem . 1993
[7]
Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and con-elation with cobalamin and folate concentrations in healthy subjects. Jacobsen DW. Gatautis VJ. Green R. et al. Clinical Chemistry . 1994
[8]
Hyperhomocy- steinemia and the prevalence of atherosclerotic vascular disease in patients with end -stage renal disease. Manns BJ. Burgges ED. Hyndman ME. et al. American Journal of Kidney Diseases . 1999